Integrating Experimental and Analytic Approaches to Improve Data Quality in Genome-wide RNAi Screens

@article{Zhang2008IntegratingEA,
  title={Integrating Experimental and Analytic Approaches to Improve Data Quality in Genome-wide RNAi Screens},
  author={Xiaohua Douglas Zhang and Amy S. Espeseth and Eric N Johnson and Jayne Chin and Adam T. Gates and Lyndon J. Mitnaul and Shane D. Marine and Jenny Tian and Erica M. Stec and Priya Kunapuli and Daniel J. Holder and Joseph F. Heyse and Berta Strulovici and Marc Ferrer},
  journal={Journal of Biomolecular Screening},
  year={2008},
  volume={13},
  pages={378 - 389}
}
RNA interference (RNAi) not only plays an important role in drug discovery but can also be developed directly into drugs. RNAi high-throughput screening (HTS) biotechnology allows us to conduct genome-wide RNAi research. A central challenge in genome-wide RNAi research is to integrate both experimental and computational approaches to obtain high quality RNAi HTS assays. Based on our daily practice in RNAi HTS experiments, we propose the implementation of 3 experimental and analytic processes to… 
View on SAGE
ncbi.nlm.nih.gov
35 Citations
Highly Influential Citations
3
Background Citations
10
Methods Citations
10

Figures and Tables from this paper

35 Citations

Genome-wide screens for effective siRNAs through assessing the size of siRNA effects

The non-central t-distribution property of SSMD estimates is explored and used to extend the SSMD-based method so that it works effectively in either primary or confirmatory screens as well as in any HTS screens with or without replicates.

Genomic screening with RNAi: results and challenges.

The main findings that have emerged from RNAi HTS are reviewed and technical issues that remain to be improved are discussed, in particular the verification of RNAi results and validation of their biological relevance.

Novel Analytic Criteria and Effective Plate Designs for Quality Control in Genome-Scale RNAi Screens

Novel QC criteria are constructed for evaluating data quality in genome-wide RNAi screens based on a recently proposed parameter, strictly standardized mean difference (SSMD), and these QC criteria obtain consistent QC results for multiple positive controls with different effect sizes.

Hit selection with false discovery rate control in genome-scale RNAi screens

The proposed approach incorporates information from reliable controls to achieve a higher power and a balance between the contribution from the samples and control wells and provides false discovery rate (FDR) control to address multiple testing issues and it is robust to outliers.

The Use of Design Specificity in Standardized Mean Difference for Analysis of High throughput RNA Interference Screens

A new extension of theSSMD is described, which integrates bioinformatics RNAi on-target analysis results for both the SSMD-based testing process and the use of SSMD as a ranking metric for hit selection by using additional controls generated from RNAi libraries.

RNA interference in mammals: behind the screen.

A number of critical aspects to consider when planning an effective RNAi screening strategy are discussed, including selecting the right biological system, designing an appropriate selection scheme, optimizing technical aspects of the screen, and validating and verifying the hits.

Statistical methods for analysis of high-throughput RNA interference screens

This work examines the similarities and differences between RNAi and small-molecule screens, highlighting particular characteristics of RNAi screen data that must be addressed during analysis and provides guidance on selection of analysis techniques in the context of a sample workflow.

Comprehensive analysis of high-throughput screens with HiTSeekR

Three use cases are chosen that demonstrate the potential of HiTSeekR to fully exploit HTS screening data in quite heterogeneous contexts to generate novel hypotheses for follow-up experiments and are the first approach to close the gap between raw data processing, network enrichment and wet lab target generation for various HTS screen types.

Error Rates and Powers in Genome-Scale RNAi Screens

The authors illustrate how to maintain a balanced control of both FNR and RFPR using the plot of error rate versus SSMD as well as how to keep high powers using theplot of power versus SS MD in RNAi high-throughput screening experiments.

Data Analysis Approaches in High Throughput Screening

Screening of diverse small molecule libraries against a known target or disease-relevant pathway facilitates the discovery of chemical tools as candidates for further development.

References

SHOWING 1-10 OF 39 REFERENCES

A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays.

Median Absolute Deviation to Improve Hit Selection for Genome-Scale RNAi Screens

The authors demonstrate that the MAD-based hit selection method rescued physiologically relevant false negatives that would have been missed in the SD-based method, and they believe it to be the desirable 1st-choice hitselection method for RNAi screen results.

Novel Analytic Criteria and Effective Plate Designs for Quality Control in Genome-Scale RNAi Screens

Novel QC criteria are constructed for evaluating data quality in genome-wide RNAi screens based on a recently proposed parameter, strictly standardized mean difference (SSMD), and these QC criteria obtain consistent QC results for multiple positive controls with different effect sizes.

Increasing the robustness and validity of RNAi screens.

This review will discuss how approaches can improve RNAi screening data at the community level and for an individual researcher trying to manage an RNAi screen.

High-throughput screening of effective siRNAs from RNAi libraries delivered via bacterial invasion

It is demonstrated that functional short hairpin RNAs (shRNAs) could be synthesized in Escherichia coli and delivered directly via bacterial invasion to the near entirety of a mammalian cell population to trigger RNAi.

The Use of Strictly Standardized Mean Difference for Hit Selection in Primary RNA Interference High-Throughput Screening Experiments

The applications presented in this article demonstrate that the SSMD method addresses scientific questions and fills scientific needs better than both percentage inhibition and the commonly used z-score method for hit selection.

Translating RNA interference into therapies for human disease.

The process of selecting an RNAi-based drug candidate may simply involve the synthesis and testing of a relatively small number of short double strands of RNA, incorporating chemical modifications that confer stability and direct these RNA duplexes to the appropriate tissues and cells, and/or formulating these RNA Duplexes with appropriate delivery agents to achieve the same goals.

High-Throughput Screening by RNA Interference: Control of Two Distinct Types of Variance

Basic guidelines for screen development are outlined that will help the researcher to control these forms of variance and maximize the utility of genome-wide RNAi screening.

Design and implementation of high-throughput RNAi screens in cultured Drosophila cells

This protocol offers a set of suggestions and considerations for screen optimization and a step-by-step description of the procedures successfully used at the Drosophila RNAi Screening Center for screen implementation, data collection and analysis to identify potential hits.

A large-scale RNAi screen in human cells identifies new components of the p53 pathway

The construction of a set of retroviral vectors encoding 23,742 distinct shRNAs, which target 7,914 different human genes for suppression, is reported, which confers resistance to both p53-dependent and p19ARF-dependent proliferation arrest, and abolishes a DNA-damage-induced G1 cell-cycle arrest.